Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biocon Insulin Plant Gets FDA Form 483s As Aspart Awaits Action
Six Observations Issued By US Agency Following On-Site Pre-Approval Inspection
Sep 27 2021
•
By
David Wallace
Biocon’s insulin aspart plant has received six Form 483 observations • Source: Alamy
More from Manufacturing
More from Business